Sélectionner une page

Elisabeth PORCHER

Business Development Manager

Osteosarcoma, rheumatoid arthritis, osteoarthritis

Atlanthera is a drug discovery company focusing on bone diseases and bone cancer treatments.

Atlanthera owns a portfolio of molecules with the capacity to target bone tissue. We are developing several programs based on this concept and our lead candidate, 12b80, in the field of oncology, is now ready for the clinical stage.

Besides Atlanthera diversifies its therapeutic strategy to the osteoarticular targeting of anti-rheumatoid drugs (anti-inflammatory, antalgic and anti-chondrodegradation strategies) as well as anti-microbial drugs.